Effectiveness of calcipotriol/betamethasone dipropionate aerosol foam in patients with small versus large plaque psoriasis in routine practice in South Korea
Seong Jin Jo, Chul-Jong Park, Chul Hwan Bang, Ki-Heon Jeong, Bong Seok Shin, Dong Hyun Kim, Hae Jun Song, Ju-Hee Lee, YoungEun Kim, Sun Choi, Sang Woong Youn
{"title":"Effectiveness of calcipotriol/betamethasone dipropionate aerosol foam in patients with small versus large plaque psoriasis in routine practice in South Korea","authors":"Seong Jin Jo, Chul-Jong Park, Chul Hwan Bang, Ki-Heon Jeong, Bong Seok Shin, Dong Hyun Kim, Hae Jun Song, Ju-Hee Lee, YoungEun Kim, Sun Choi, Sang Woong Youn","doi":"10.1111/1346-8138.17253","DOIUrl":null,"url":null,"abstract":"<p>Small plaque psoriasis is the typical form of chronic plaque psoriasis affecting adults in South Korea. The effectiveness of calcipotriol/betamethasone dipropionate (Cal/BD) aerosol foam for large and small psoriasis plaques has not previously been examined. We performed a post hoc analysis of a recent, 4-week observational study of Cal/BD aerosol foam use in routine clinical practice in South Korea. Investigator Global Assessment response ([IGA] 0/1 at week 4), Patient Global Assessment response ([PaGA] 0/1 at week 4), change in Psoriasis Area and Severity Index (PASI), changes in psoriasis symptom scores, change in the Dermatology Life Quality Index (DLQI), and the proportion of patients achieving DLQI ≤5 were analyzed for patients with small (≤5 cm; <i>n</i> = 131) or large (>5 cm; <i>n</i> = 35) baseline plaque size. IGA response rates were similar for patients with small and large plaques (59.5% and 51.4% respectively). Similarly, there was no significant difference between the small and large groups in mean change in PASI (−2.20 vs −3.34), the proportions of patients with DLQI ≤5 (62.3% vs 54.3%) or PaGA 0/1 (29.2% vs 40.0%). Mean improvements in DLQI (−4.04 vs −6.20) and in psoriasis symptoms including itching (−1.50 vs −2.83), sleep loss (−0.67 vs −1.89), dryness (−1.57 vs −2.97), scaling (−1.21 vs −3.57), and redness (−1.17 vs −3.11) were greater in patients with large plaques than those with small plaques. Itching and DLQI differences were not statistically significant after adjustment for baseline characteristics. Stratification by body surface area affected eliminated statistically significant differences between the groups for most outcomes. In conclusion, this analysis suggests that Cal/BD aerosol foam is an effective, well-accepted treatment for adult patients with the small plaques typical of chronic plaque psoriasis in South Korea, as well as for those with large plaques.</p>","PeriodicalId":54848,"journal":{"name":"Journal of Dermatology","volume":"51 7","pages":"1010-1016"},"PeriodicalIF":2.9000,"publicationDate":"2024-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1346-8138.17253","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Dermatology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/1346-8138.17253","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Small plaque psoriasis is the typical form of chronic plaque psoriasis affecting adults in South Korea. The effectiveness of calcipotriol/betamethasone dipropionate (Cal/BD) aerosol foam for large and small psoriasis plaques has not previously been examined. We performed a post hoc analysis of a recent, 4-week observational study of Cal/BD aerosol foam use in routine clinical practice in South Korea. Investigator Global Assessment response ([IGA] 0/1 at week 4), Patient Global Assessment response ([PaGA] 0/1 at week 4), change in Psoriasis Area and Severity Index (PASI), changes in psoriasis symptom scores, change in the Dermatology Life Quality Index (DLQI), and the proportion of patients achieving DLQI ≤5 were analyzed for patients with small (≤5 cm; n = 131) or large (>5 cm; n = 35) baseline plaque size. IGA response rates were similar for patients with small and large plaques (59.5% and 51.4% respectively). Similarly, there was no significant difference between the small and large groups in mean change in PASI (−2.20 vs −3.34), the proportions of patients with DLQI ≤5 (62.3% vs 54.3%) or PaGA 0/1 (29.2% vs 40.0%). Mean improvements in DLQI (−4.04 vs −6.20) and in psoriasis symptoms including itching (−1.50 vs −2.83), sleep loss (−0.67 vs −1.89), dryness (−1.57 vs −2.97), scaling (−1.21 vs −3.57), and redness (−1.17 vs −3.11) were greater in patients with large plaques than those with small plaques. Itching and DLQI differences were not statistically significant after adjustment for baseline characteristics. Stratification by body surface area affected eliminated statistically significant differences between the groups for most outcomes. In conclusion, this analysis suggests that Cal/BD aerosol foam is an effective, well-accepted treatment for adult patients with the small plaques typical of chronic plaque psoriasis in South Korea, as well as for those with large plaques.
在韩国,小斑块银屑病是影响成年人的慢性斑块银屑病的典型形式。钙泊三醇/二丙酸倍他米松(Cal/BD)气雾剂泡沫对大面积和小面积银屑病斑块的疗效尚未进行过研究。我们对最近在韩国常规临床实践中使用 Cal/BD 气雾剂泡沫的一项为期 4 周的观察性研究进行了事后分析。我们分析了基线斑块大小为小(≤5 厘米;n = 131)或大(>5 厘米;n = 35)的患者的研究者全球评估反应([IGA] 0/1,第 4 周)、患者全球评估反应([PaGA] 0/1,第 4 周)、银屑病面积和严重程度指数(PASI)变化、银屑病症状评分变化、皮肤科生活质量指数(DLQI)变化以及达到 DLQI≤5 的患者比例。小斑块和大斑块患者的 IGA 反应率相似(分别为 59.5% 和 51.4%)。同样,在 PASI 平均变化(-2.20 vs -3.34)、DLQI ≤5 的患者比例(62.3% vs 54.3%)或 PaGA 0/1 的患者比例(29.2% vs 40.0%)方面,小斑块组和大斑块组也没有明显差异。大斑块患者的 DLQI(-4.04 vs -6.20)和银屑病症状(包括瘙痒(-1.50 vs -2.83)、失眠(-0.67 vs -1.89)、干燥(-1.57 vs -2.97)、脱屑(-1.21 vs -3.57)和发红(-1.17 vs -3.11))的平均改善程度高于小斑块患者。对基线特征进行调整后,瘙痒和 DLQI 差异无统计学意义。根据体表面积进行分层后,大多数结果的组间差异均无统计学意义。总之,这项分析表明,对于韩国典型的慢性斑块型银屑病小斑块成年患者和大斑块成年患者来说,Cal/BD 气雾剂泡沫是一种有效且广为接受的治疗方法。
期刊介绍:
The Journal of Dermatology is the official peer-reviewed publication of the Japanese Dermatological Association and the Asian Dermatological Association. The journal aims to provide a forum for the exchange of information about new and significant research in dermatology and to promote the discipline of dermatology in Japan and throughout the world. Research articles are supplemented by reviews, theoretical articles, special features, commentaries, book reviews and proceedings of workshops and conferences.
Preliminary or short reports and letters to the editor of two printed pages or less will be published as soon as possible. Papers in all fields of dermatology will be considered.